| molecular function |
|---|
| | GO:0031701 | | angiotensin receptor binding | | Interacting selectively and non-covalently with an angiotensin receptor. |
| | GO:0008083 | | growth factor activity | | The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
| | GO:0005179 | | hormone activity | | The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0048018 | | receptor agonist activity | | Interacts with receptors such that the proportion of receptors in the active form is increased. |
| | GO:0004867 | | serine-type endopeptidase inhibitor activity | | Stops, prevents or reduces the activity of serine-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme. |
| | GO:0017080 | | sodium channel regulator activity | | Modulates the activity of a sodium channel. |
| | GO:0016176 | | superoxide-generating NADPH oxidase activator activity | | Increases the activity of the enzyme superoxide-generating NADPH oxidase. |
| | GO:0031702 | | type 1 angiotensin receptor binding | | Interacting selectively and non-covalently with a type 1 angiotensin receptor. |
| | GO:0031703 | | type 2 angiotensin receptor binding | | Interacting selectively and non-covalently with a type 2 angiotensin receptor. |
| biological process |
|---|
| | GO:0070371 | | ERK1 and ERK2 cascade | | An intracellular protein kinase cascade containing at least ERK1 or ERK2 (MAPKs), a MEK (a MAPKK) and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell. |
| | GO:0007186 | | G-protein coupled receptor signaling pathway | | A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576). |
| | GO:0007199 | | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger | | The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, followed by activation of guanylyl cyclase (GC) activity and a subsequent increase in the concentration of cyclic GMP (cGMP). |
| | GO:0007202 | | activation of phospholipase C activity | | The initiation of the activity of the inactive enzyme phospolipase C as the result of a series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand. |
| | GO:0007568 | | aging | | A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
| | GO:0002003 | | angiotensin maturation | | The process leading to the attainment of the full functional capacity of angiotensin by conversion of renin substrate into mature angiotensin in the blood. |
| | GO:0038166 | | angiotensin-activated signaling pathway | | The series of molecular signals generated as a consequence of angiotensin II binding to an angiotensin receptor on the surface of the cell, and proceeding with the activated receptor transmitting the signal to a heterotrimeric G-protein complex to initiate a change in cell activity. Ends with regulation of a downstream cellular process, e.g. transcription. |
| | GO:0003051 | | angiotensin-mediated drinking behavior | | The drinking behavior that is mediated by the action of angiotensin in the brain. Angiotensin stimulates the brain centers that control thirst. |
| | GO:0014824 | | artery smooth muscle contraction | | A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. This process occurs in the artery. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. The artery is a vessel carrying blood away from the heart. |
| | GO:0001974 | | blood vessel remodeling | | The reorganization or renovation of existing blood vessels. |
| | GO:0035411 | | catenin import into nucleus | | The directed movement of a catenin protein from the cytoplasm into the nucleus. |
| | GO:0061049 | | cell growth involved in cardiac muscle cell development | | The growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state. |
| | GO:0007166 | | cell surface receptor signaling pathway | | A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
| | GO:0007267 | | cell-cell signaling | | Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions. |
| | GO:0071260 | | cellular response to mechanical stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
| | GO:0006883 | | cellular sodium ion homeostasis | | Any process involved in the maintenance of an internal steady state of sodium ions at the level of a cell. |
| | GO:0050663 | | cytokine secretion | | The regulated release of cytokines from a cell. Cytokines are any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity. |
| | GO:0007565 | | female pregnancy | | The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. |
| | GO:0048144 | | fibroblast proliferation | | The multiplication or reproduction of fibroblast cells, resulting in the expansion of the fibroblast population. |
| | GO:0001822 | | kidney development | | The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine. |
| | GO:0034374 | | low-density lipoprotein particle remodeling | | The acquisition, loss or modification of a protein or lipid within a low-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters from LDL to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride to LDL. |
| | GO:0016525 | | negative regulation of angiogenesis | | Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis. |
| | GO:0030308 | | negative regulation of cell growth | | Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth. |
| | GO:0010951 | | negative regulation of endopeptidase activity | | Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins. |
| | GO:0010629 | | negative regulation of gene expression | | Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| | GO:0051387 | | negative regulation of neurotrophin TRK receptor signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of the neurotrophin TRK receptor signaling pathway. |
| | GO:2000650 | | negative regulation of sodium ion transmembrane transporter activity | | Any process that stops, prevents or reduces the frequency, rate or extent of sodium ion transmembrane transporter activity. |
| | GO:0034104 | | negative regulation of tissue remodeling | | Any process that stops, prevents, or reduces the frequency, rate, or extent of tissue remodeling. |
| | GO:0007263 | | nitric oxide mediated signal transduction | | Any intracellular signal transduction in which the signal is passed on within the cell via nitric oxide (NO). Includes synthesis of nitric oxide, receptors/sensors for nitric oxide (such as soluble guanylyl cyclase/sGC) and downstream effectors that further transmit the signal within the cell. Nitric oxide transmits its downstream effects through either cyclic GMP (cGMP)-dependent or independent mechanisms. |
| | GO:0007200 | | phospholipase C-activating G-protein coupled receptor signaling pathway | | The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, where the pathway proceeds with activation of phospholipase C (PLC) and a subsequent increase in the concentration of inositol trisphosphate (IP3) and diacylglycerol (DAG). |
| | GO:0033864 | | positive regulation of NAD(P)H oxidase activity | | Any process that activates or increases the activity of the enzyme NAD(P)H oxidase. |
| | GO:0051092 | | positive regulation of NF-kappaB transcription factor activity | | Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB. |
| | GO:0045777 | | positive regulation of blood pressure | | Any process in which the force of blood traveling through the circulatory system is increased. |
| | GO:0090190 | | positive regulation of branching involved in ureteric bud morphogenesis | | Any process that increases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules. |
| | GO:0010613 | | positive regulation of cardiac muscle hypertrophy | | Any process that increases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division. |
| | GO:0043085 | | positive regulation of catalytic activity | | Any process that activates or increases the activity of an enzyme. |
| | GO:0008284 | | positive regulation of cell proliferation | | Any process that activates or increases the rate or extent of cell proliferation. |
| | GO:0032270 | | positive regulation of cellular protein metabolic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell. |
| | GO:0010873 | | positive regulation of cholesterol esterification | | Any process that increases the frequency, rate or extent of cholesterol esterification. Cholesterol esterification is the lipid modification process in which a sterol ester is formed by the combination of a carboxylic acid (often a fatty acid) and cholesterol. In the blood this process is associated with the conversion of free cholesterol into cholesteryl ester, which is then sequestered into the core of a lipoprotein particle. |
| | GO:0001819 | | positive regulation of cytokine production | | Any process that activates or increases the frequency, rate or extent of production of a cytokine. |
| | GO:0010595 | | positive regulation of endothelial cell migration | | Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
| | GO:0045742 | | positive regulation of epidermal growth factor receptor signaling pathway | | Any process that activates or increases the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity. |
| | GO:0003331 | | positive regulation of extracellular matrix constituent secretion | | Any process that increases the rate, frequency, or extent of the controlled release of molecules that form the extracellular matrix, including carbohydrates and glycoproteins by a cell or a group of cells. |
| | GO:2001238 | | positive regulation of extrinsic apoptotic signaling pathway | | Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway. |
| | GO:0048146 | | positive regulation of fibroblast proliferation | | Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells. |
| | GO:1903598 | | positive regulation of gap junction assembly | | Any process that activates or increases the frequency, rate or extent of gap junction assembly. |
| | GO:0050729 | | positive regulation of inflammatory response | | Any process that activates or increases the frequency, rate or extent of the inflammatory response. |
| | GO:0010744 | | positive regulation of macrophage derived foam cell differentiation | | Any process that increases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions. |
| | GO:1902632 | | positive regulation of membrane hyperpolarization | | Any process that activates or increases the frequency, rate or extent of membrane hyperpolarization. |
| | GO:0045429 | | positive regulation of nitric oxide biosynthetic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide. |
| | GO:0050731 | | positive regulation of peptidyl-tyrosine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
| | GO:0014068 | | positive regulation of phosphatidylinositol 3-kinase signaling | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
| | GO:0061098 | | positive regulation of protein tyrosine kinase activity | | Any process that increases the rate, frequency, or extent of protein tyrosine kinase activity. |
| | GO:2000379 | | positive regulation of reactive oxygen species metabolic process | | Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process. |
| | GO:0035815 | | positive regulation of renal sodium excretion | | Any process that increases the amount of sodium excreted in urine over a unit of time. |
| | GO:0032930 | | positive regulation of superoxide anion generation | | Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell. |
| | GO:0045893 | | positive regulation of transcription, DNA-templated | | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
| | GO:0008217 | | regulation of blood pressure | | Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure. |
| | GO:0002034 | | regulation of blood vessel diameter by renin-angiotensin | | The process in which the diameter of a blood vessel is changed due to activity of the renin-angiotensin system. |
| | GO:0050880 | | regulation of blood vessel size | | Any process that modulates the size of blood vessels. |
| | GO:0002016 | | regulation of blood volume by renin-angiotensin | | The process in which the renin-angiotensin system controls the rate of fluid intake and output into the blood. |
| | GO:0051924 | | regulation of calcium ion transport | | Any process that modulates the frequency, rate or extent of the directed movement of calcium ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| | GO:1903779 | | regulation of cardiac conduction | | Any process that modulates the frequency, rate or extent of cardiac conduction. |
| | GO:0001558 | | regulation of cell growth | | Any process that modulates the frequency, rate, extent or direction of cell growth. |
| | GO:0042127 | | regulation of cell proliferation | | Any process that modulates the frequency, rate or extent of cell proliferation. |
| | GO:1901201 | | regulation of extracellular matrix assembly | | Any process that modulates the frequency, rate or extent of extracellular matrix assembly. |
| | GO:0002027 | | regulation of heart rate | | Any process that modulates the frequency or rate of heart contraction. |
| | GO:0048169 | | regulation of long-term neuronal synaptic plasticity | | A process that modulates long-term neuronal synaptic plasticity, the ability of neuronal synapses to change long-term as circumstances require. Long-term neuronal synaptic plasticity generally involves increase or decrease in actual synapse numbers. |
| | GO:0014061 | | regulation of norepinephrine secretion | | Any process that modulates the frequency, rate or extent of the regulated release of norepinephrine. |
| | GO:0002019 | | regulation of renal output by angiotensin | | The process in which angiotensin directly modulates the rate of urine output by the kidney. |
| | GO:0035813 | | regulation of renal sodium excretion | | Any process that modulates the amount of sodium excreted in urine over a unit of time. |
| | GO:0003081 | | regulation of systemic arterial blood pressure by renin-angiotensin | | The process in which renin-angiotensin modulates the force with which blood passes through the circulatory system. |
| | GO:0051969 | | regulation of transmission of nerve impulse | | Any process that modulates the frequency, rate or extent of transmission of a nerve impulse, the sequential electrochemical polarization and depolarization that travels across the membrane of a neuron in response to stimulation. |
| | GO:0019229 | | regulation of vasoconstriction | | Any process that modulates the frequency, rate or extent of reductions in the diameter of blood vessels. |
| | GO:0003014 | | renal system process | | A organ system process carried out by any of the organs or tissues of the renal system. The renal system maintains fluid balance, and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products. In humans, the renal system comprises a pair of kidneys, a pair of ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels; in other species, the renal system may comprise related structures (e.g., nephrocytes and malpighian tubules in Drosophila). |
| | GO:0002018 | | renin-angiotensin regulation of aldosterone production | | The process in which an increase in active angiotensin stimulates the adrenal cortices to secrete aldosterone. |
| | GO:0014873 | | response to muscle activity involved in regulation of muscle adaptation | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muscle activity stimulus. This process occurs as part of the regulation of muscle adaptation. |
| | GO:0048659 | | smooth muscle cell proliferation | | The multiplication or reproduction of smooth muscle cells, resulting in the expansion of a cell population. |
| | GO:0051403 | | stress-activated MAPK cascade | | A series of molecular signals in which a stress-activated MAP kinase cascade relays one or more of the signals; MAP kinase cascades involve at least three protein kinase activities and culminate in the phosphorylation and activation of a MAP kinase. |
| | GO:0070471 | | uterine smooth muscle contraction | | A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. This process occurs in the uterus. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. The uterus is a muscular organ of the female mammal for containing and usually for nourishing the young during development prior to birth. |
| | GO:0042310 | | vasoconstriction | | A decrease in the diameter of blood vessels, especially arteries, due to constriction of smooth muscle cells that line the vessels, and usually causing an increase in blood pressure. |
| | GO:0042311 | | vasodilation | | An increase in the internal diameter of blood vessels, especially arterioles or capillaries, due to relaxation of smooth muscle cells that line the vessels, and usually resulting in a decrease in blood pressure. |
| cellular component |
|---|
| | GO:0072562 | | blood microparticle | | A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids. |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| | GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
Description
